Seventy Detransitioners Come to Washington
Largest-ever assembly of detransitioners will join clinicians, researchers, lawyers, and policymakers to chart what needs to happen next
On March 12, something unprecedented will take place in Washington DC. For the first time ever, roughly 70 detransitioners will gather in one place to mark Detrans Awareness Day. Many of them will be meeting another detransitioner face-to-face for the first time in their lives.
That fact alone tells you something about the reality of detransition. A common comment in our support groups is that transition is easy and often cheered along, but detransition is difficult and isolating. Many people who have stopped or reversed a medical gender transition do so in secret, trying to piece together their lives while navigating complex psychological, medical, social, and legal consequences. Until very recently, there have been few spaces where they could meet others and speak about shared experiences.
This gathering changes that.
Hosted by Genspect in the heart of Washington, DC, the event will bring together detransitioners, regretters, detrans-curious individuals, clinicians, researchers, lawyers, and policymakers to examine the trans phenomenon and consider what must happen next. The conference itself will be livestreamed so that the public can hear directly from people who have experienced medical transition and later come to regret it.
But the most important conversations will happen away from the cameras. During the afternoon, detransitioners will have the opportunity to take part in private roundtable discussions with some of the leading legal experts in the world. These sessions are designed to give participants space to ask questions, share experiences, and explore possible legal avenues with specialists who understand the complexities of medical harm, informed consent, and institutional accountability. For many detransitioners, this will be the first time they have been able to speak directly with lawyers who have devoted serious thought to these questions.
Alongside the legal roundtable discussions, doctors and endocrinologists will also be available to provide information about the medical realities of transition and detransition. Leading researchers will take part in roundtables focused on identifying the needs of this growing population. Representatives from the LGB Alliance will attend to assess the social challenges faced by detransitioners and to consider how communities can better support those navigating the aftermath of transition.
The day will bring together voices from both sides of the Atlantic and as far away as New Zealand. Several well-known British detransitioners, including Keira Bell and Ritchie Herron, whose stories were among the first to gain worldwide attention, will travel to Washington to take part in the discussions. They will appear alongside emerging American voices such as Jonni Skinner and Jessi Harris, whose experiences of detransition are only beginning to enter public consciousness. Their testimonies, along with those of many others attending the conference, will offer a rare opportunity to hear directly from people whose lives have been shaped by medical transition and its consequences.
The presence of senior policymakers underlines the seriousness of the issue. Chairman Andrew Ferguson of the Federal Trade Commission will deliver the keynote address, while Admiral Brian Christine of the US Department of Health and Human Services will give the closing speech. Their participation reflects a growing recognition that the medicalization of gender distress raises questions that extend far beyond medicine alone. Regulation, consumer protection, ethics, and public policy are all implicated in what has become one of the most controversial areas of modern healthcare.
Consumer-driven ‘Healthcare’
The issues raised by detransition reach beyond individual regret and point to a deeper shift in medicine itself. In recent years, parts of healthcare have moved away from a traditional patient-care model toward something closer to a consumerist ethic. The medical principle of “first, do no harm” has increasingly been replaced by a marketplace logic of “buyer beware.” Clinicians once understood their role as guiding vulnerable patients through distress with caution and restraint. In the field of gender medicine, that role has often been reframed as helping individuals achieve what are now called “embodiment goals,” a phrase that reflects a subtle but significant change in thinking.
As the political and legal problems associated with self-ID have become more widely recognized, the language has shifted, yet the underlying premise remains similar: that medicine should reshape the body in order to satisfy a declared identity. The ethical questions raised by this shift are examined in detail in The Gender Framework, a new book that will be launched at the conference. In one chapter, the philosopher Holly Lawford-Smith offers a clear account of how societies can navigate conflicts when two groups believe their rights are at stake. Her analysis provides a valuable lens through which to understand the tensions now unfolding around gender identity, medicine, ethics, and law.
At the conference, we will also launch the Beyond Trans Database, a major new initiative designed to document the experiences of individuals who have undergone medical transition and later regretted it. Participants will have the opportunity to record their encounters with gender clinics and gender affirming clinicians, the treatments they received, and the outcomes they experienced.
This database will be publicly available, providing a resource for lawyers, policymakers, journalists, analysts, and anyone seeking to understand the human consequences of this ongoing medical experiment. It will also serve as a record of promises made and promises broken by institutions that once presented transition as a straightforward path to discovering one’s authentic self.
‘Harmed by Medical Transition’
Detransition is rarely straightforward. It can involve psychological devastation, social isolation, challenging medical complications that nobody seems to understand, and legal uncertainty without resolution. At Genspect, we have seen this firsthand through the hundreds of Beyond Trans therapeutic meetings we run every year. These meetings bring together over 600 detransitioners, regretters, detrans curious, individuals who identify as trans but are experiencing difficulties, and others who feel harmed by the ideology surrounding gender identity. Alongside this work, we support more than 5000 parents navigating similar challenges within their families.
One pattern emerges repeatedly in our support meetings. The moment when someone begins to suspect that their medical transition may have been a mistake can be one of the most dangerous periods of their life. Suicidality appears to be at its highest when the promises made by clinicians and activists alike collide with the reality of being disappointed by medical transition.
For this reason, we often use the phrase “harmed by medical transition” when discussing the issue in legal and policy contexts. The words “transition” and “detransition” do not adequately capture what many people have experienced. They suggest a personal journey or identity change rather than the medical interventions that took place. The phrase “harmed by medical transition” highlights something else - the responsibility of institutions that promoted irreversible, life-altering medical interventions without adequate evidence, caution, or safeguards. It directs attention to the systems that authorized vulnerable people to undergo permanent medical procedures without sufficient scrutiny.
Detrans Awareness Day represents a beginning rather than an end. Our hope is that this pioneering gathering will lead to many more in the years ahead, bringing together hundreds of detransitioners and ensuring that their voices are heard at the highest levels of public life.
Your Support Support Matters
For this work to continue, support is essential. Bringing detransitioners to Washington, hosting the conference, and building the Beyond Trans Database have required enormous effort and substantial funding.
If you believe that people harmed by medical transition deserve to be heard, supported, and taken seriously, please consider helping us make this work possible. Donations allow us to bring detransitioners together, provide therapeutic support, and ensure that their experiences inform the policies that will shape the future.
On March 12, 70 people who were once told that transition would solve their problems will gather in the political heart of the United States to tell a different story. It is a story that the world needs to hear.
If you are a detransitioner and would like to attend Detrans Awareness Day in Washington, DC, on March 12th, funding support is available. Please email beyond@genspect.org to apply. You can also support this historic event by attending in person, joining online, or making a donation to support detransitioners.